NEW YORK (GenomeWeb) – Digital PCR can better detect hints of residual disease in chronic myeloid leukemia patients than other PCR-based approaches, according to a team of UK researchers.

With tyrosine kinase inhibitor (TKI) treatment, CML can be rendered nearly undetectable in patients. But while some patients remain disease-free after treatment is halted, others can relapse. This, the researchers said, highlights the need for ways to detect even low levels of disease.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

NPR reports that with medical data being big business, some companies want to get patients involved.

The Asbury Park Press reports on the startup Genomic Prediction's test to determine an embryo's risk of disease.

In PNAS this week: optical mapping allows glimpse of structural variants, disease-linked GATA2 mutations boosts its protein activity, and more.

Senator Elizabeth Warren (D-Mass.) has released the results of a genetic ancestry analysis, the Boston Globe reports.

Sponsored by

This webinar will provide a first-hand look at how a leading pathology lab implemented a next-generation sequencing panel to capture comprehensive molecular tumor profiles.

Sponsored by

This webinar will discuss how understanding the relative performance characteristics of glass and polymer substrates for in vitro diagnostic applications such as microarrays and microfluidics can help to optimize diagnostic performance.